{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:38:16Z","timestamp":1773297496544,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00701-018-3563-3","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T04:29:54Z","timestamp":1527136194000},"page":"1451-1460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications"],"prefix":"10.1007","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9741-7640","authenticated-orcid":false,"given":"Olivia","family":"N\u00e4slund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Smits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petter","family":"F\u00f6rander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Laesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Jiri","family":"Bartek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Gempt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Liljegren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva-Lotte","family":"Daxberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asgeir Store","family":"Jakola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"key":"3563_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/neuonc\/now058","volume":"18","author":"NL Albert","year":"2016","unstructured":"Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, la Fougere C, Pope W, Law I, Arbizu J, Chamberlain MC, Vogelbaum M, Ellingson BM, Tonn JC (2016) Response assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro-Oncology 18:1199\u20131208. \n                    https:\/\/doi.org\/10.1093\/neuonc\/now058","journal-title":"Neuro-Oncology"},{"key":"3563_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00259-015-3276-2","volume":"43","author":"NL Albert","year":"2016","unstructured":"Albert NL, Winkelmann I, Suchorska B, Wenter V, Schmid-Tannwald C, Mille E, Todica A, Brendel M, Tonn JC, Bartenstein P, la Fougere C (2016) Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40\u00a0min scans. Eur J Nucl Med Mol Imaging 43:1105\u20131114. \n                    https:\/\/doi.org\/10.1007\/s00259-015-3276-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3563_CR3","doi-asserted-by":"publisher","unstructured":"Bashir A, Brennum J, Broholm H, Law I (2018) The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[(18)F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study. J Neurosurg:1\u201314. doi:\n                    https:\/\/doi.org\/10.3171\/2017.8.JNS171577","DOI":"10.3171\/2017.8.JNS171577"},{"key":"3563_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11060-013-1178-3","volume":"114","author":"SG Berntsson","year":"2013","unstructured":"Berntsson SG, Falk A, Savitcheva I, Godau A, Zetterling M, Hesselager G, Alafuzoff I, Larsson EM, Smits A (2013) Perfusion and diffusion MRI combined with 11C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas. J Neuro-Oncol 114:241\u2013249. \n                    https:\/\/doi.org\/10.1007\/s11060-013-1178-3","journal-title":"J Neuro-Oncol"},{"key":"3563_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.wneu.2016.01.085","volume":"89","author":"S Bette","year":"2016","unstructured":"Bette S, Gempt J, Delbridge C, Kirschke JS, Schlegel J, Foerster S, Huber T, Pyka T, Zimmer C, Meyer B, Ringel F (2016) Prognostic value of O-(2-[18F]-fluoroethyl)-L-tyrosine-positron emission tomography imaging for histopathologic characteristics and progression-free survival in patients with low-grade glioma. World Neurosurgery 89:230\u2013239. \n                    https:\/\/doi.org\/10.1016\/j.wneu.2016.01.085","journal-title":"World Neurosurgery"},{"key":"3563_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/RLI.0b013e31827188d6","volume":"48","author":"S Bisdas","year":"2013","unstructured":"Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, Naegele T, Ernemann U (2013) Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes. Investig Radiol 48:295\u2013301. \n                    https:\/\/doi.org\/10.1097\/RLI.0b013e31827188d6","journal-title":"Investig Radiol"},{"key":"3563_CR7","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"N Cancer Genome Atlas Research","year":"2015","unstructured":"Cancer Genome Atlas Research N, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, Akbani R, Huse JT, Ciriello G, Poisson LM, Barnholtz-Sloan JS, Berger MS, Brennan C, Colen RR, Colman H, Flanders AE, Giannini C, Grifford M, Iavarone A, Jain R, Joseph I, Kim J, Kasaian K, Mikkelsen T, Murray BA, O'Neill BP, Pachter L, Parsons DW, Sougnez C, Sulman EP, Vandenberg SR, Van Meir EG, von Deimling A, Zhang H, Crain D, Lau K, Mallery D, Morris S, Paulauskis J, Penny R, Shelton T, Sherman M, Yena P, Black A, Bowen J, Dicostanzo K, Gastier-Foster J, Leraas KM, Lichtenberg TM, Pierson CR, Ramirez NC, Taylor C, Weaver S, Wise L, Zmuda E, Davidsen T, Demchok JA, Eley G, Ferguson ML, Hutter CM, Mills Shaw KR, Ozenberger BA, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Ayala B, Baboud J, Chudamani S, Jensen MA, Liu J, Pihl T, Raman R, Wan Y, Wu Y, Ally A, Auman JT, Balasundaram M, Balu S, Baylin SB, Beroukhim R, Bootwalla MS, Bowlby R, Bristow CA, Brooks D, Butterfield Y, Carlsen R, Carter S, Chin L, Chu A, Chuah E, Cibulskis K, Clarke A, Coetzee SG, Dhalla N, Fennell T, Fisher S, Gabriel S, Getz G, Gibbs R, Guin R, Hadjipanayis A, Hayes DN, Hinoue T, Hoadley K, Holt RA, Hoyle AP, Jefferys SR, Jones S, Jones CD, Kucherlapati R, Lai PH, Lander E, Lee S, Lichtenstein L, Ma Y, Maglinte DT, Mahadeshwar HS, Marra MA, Mayo M, Meng S, Meyerson ML, Mieczkowski PA, Moore RA, Mose LE, Mungall AJ, Pantazi A, Parfenov M, Park PJ, Parker JS, Perou CM, Protopopov A, Ren X, Roach J, Sabedot TS, Schein J, Schumacher SE, Seidman JG, Seth S, Shen H, Simons JV, Sipahimalani P, Soloway MG, Song X, Sun H, Tabak B, Tam A, Tan D, Tang J, Thiessen N, Triche T Jr, Van Den Berg DJ, Veluvolu U, Waring S, Weisenberger DJ, Wilkerson MD, Wong T, Wu J, Xi L, Xu AW, Yang L, Zack TI, Zhang J, Aksoy BA, Arachchi H, Benz C, Bernard B, Carlin D, Cho J, DiCara D, Frazer S, Fuller GN, Gao J, Gehlenborg N, Haussler D, Heiman DI, Iype L, Jacobsen A, Ju Z, Katzman S, Kim H, Knijnenburg T, Kreisberg RB, Lawrence MS, Lee W, Leinonen K, Lin P, Ling S, Liu W, Liu Y, Liu Y, Lu Y, Mills G, Ng S, Noble MS, Paull E, Rao A, Reynolds S, Saksena G, Sanborn Z, Sander C, Schultz N, Senbabaoglu Y, Shen R, Shmulevich I, Sinha R, Stuart J, Sumer SO, Sun Y, Tasman N, Taylor BS, Voet D, Weinhold N, Weinstein JN, Yang D, Yoshihara K, Zheng S, Zhang W, Zou L, Abel T, Sadeghi S, Cohen ML, Eschbacher J, Hattab EM, Raghunathan A, Schniederjan MJ, Aziz D, Barnett G, Barrett W, Bigner DD, Boice L, Brewer C, Calatozzolo C, Campos B, Carlotti CG Jr, Chan TA, Cuppini L, Curley E, Cuzzubbo S, Devine K, DiMeco F, Duell R, Elder JB, Fehrenbach A, Finocchiaro G, Friedman W, Fulop J, Gardner J, Hermes B, Herold-Mende C, Jungk C, Kendler A, Lehman NL, Lipp E, Liu O, Mandt R, McGraw M, McLendon R, McPherson C, Neder L, Nguyen P, Noss A, Nunziata R, Ostrom QT, Palmer C, Perin A, Pollo B, Potapov A, Potapova O, Rathmell WK, Rotin D, Scarpace L, Schilero C, Senecal K, Shimmel K, Shurkhay V, Sifri S, Singh R, Sloan AE, Smolenski K, Staugaitis SM, Steele R, Thorne L, Tirapelli DP, Unterberg A, Vallurupalli M, Wang Y, Warnick R, Williams F, Wolinsky Y, Bell S, Rosenberg M, Stewart C, Huang F, Grimsby JL, Radenbaugh AJ, Zhang J (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481\u20132498. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1402121","journal-title":"N Engl J Med"},{"key":"3563_CR8","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(05)70222-2","volume":"4","author":"R Cavaliere","year":"2005","unstructured":"Cavaliere R, Lopes MB, Schiff D (2005) Low-grade gliomas: an update on pathology and therapy. Lancet Neurol 4:760\u2013770. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(05)70222-2","journal-title":"Lancet Neurol"},{"key":"3563_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3171\/2014.12.JNS141851","volume":"124","author":"J Cochereau","year":"2016","unstructured":"Cochereau J, Herbet G, Rigau V, Duffau H (2016) Acute progression of untreated incidental WHO Grade II glioma to glioblastoma in an asymptomatic patient. J Neurosurg 124:141\u2013145. \n                    https:\/\/doi.org\/10.3171\/2014.12.JNS141851","journal-title":"J Neurosurg"},{"key":"3563_CR10","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3171\/jns.2001.95.5.0746","volume":"95","author":"O Witte De","year":"2001","unstructured":"De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, Salmon I, Brotchi J, Goldman S (2001) Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 95:746\u2013750. \n                    https:\/\/doi.org\/10.3171\/jns.2001.95.5.0746","journal-title":"J Neurosurg"},{"key":"3563_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/WCO.0000000000000490","volume":"30","author":"JC DeWitt","year":"2017","unstructured":"DeWitt JC, Mock A, Louis DN (2017) The 2016 WHO classification of central nervous system tumors: what neurologists need to know. Curr Opin Neurol 30:643\u2013649. \n                    https:\/\/doi.org\/10.1097\/WCO.0000000000000490","journal-title":"Curr Opin Neurol"},{"key":"3563_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3413\/Nukmed-0650-14-03","volume":"53","author":"V Dunet","year":"2014","unstructured":"Dunet V, Maeder P, Nicod-Lalonde M, Lhermitte B, Pollo C, Bloch J, Stupp R, Meuli R, Prior JO (2014) Combination of MRI and dynamic FET PET for initial glioma grading. Nucl Med (Stuttg) 53:155\u2013161. \n                    https:\/\/doi.org\/10.3413\/Nukmed-0650-14-03","journal-title":"Nucl Med (Stuttg)"},{"key":"3563_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.clineuro.2011.03.008","volume":"113","author":"C Ewelt","year":"2011","unstructured":"Ewelt C, Floeth FW, Felsberg J, Steiger HJ, Sabel M, Langen KJ, Stoffels G, Stummer W (2011) Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence. Clin Neurol Neurosurg 113:541\u2013547. \n                    https:\/\/doi.org\/10.1016\/j.clineuro.2011.03.008","journal-title":"Clin Neurol Neurosurg"},{"key":"3563_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3171\/jns.2005.102.2.0318","volume":"102","author":"FW Floeth","year":"2005","unstructured":"Floeth FW, Pauleit D, Wittsack HJ, Langen KJ, Reifenberger G, Hamacher K, Messing-Junger M, Zilles K, Weber F, Stummer W, Steiger HJ, Woebker G, Muller HW, Coenen H, Sabel M (2005) Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. J Neurosurg 102:318\u2013327","journal-title":"J Neurosurg"},{"key":"3563_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00259-010-1690-z","volume":"38","author":"FW Floeth","year":"2011","unstructured":"Floeth FW, Sabel M, Ewelt C, Stummer W, Felsberg J, Reifenberger G, Steiger HJ, Stoffels G, Coenen HH, Langen KJ (2011) Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas. Eur J Nucl Med Mol Imaging 38:731\u2013741. \n                    https:\/\/doi.org\/10.1007\/s00259-010-1690-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3563_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563\u2013577. \n                    https:\/\/doi.org\/10.1148\/radiol.2015151169","journal-title":"Radiology"},{"key":"3563_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13058-016-0793-2","volume":"19","author":"D Groheux","year":"2017","unstructured":"Groheux D, Martineau A, Teixeira L, Espie M, de Cremoux P, Bertheau P, Merlet P, Lemarignier C (2017) 18FDG-PET\/CT for predicting the outcome in ER+\/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis. Breast Cancer Res 19:3. \n                    https:\/\/doi.org\/10.1186\/s13058-016-0793-2","journal-title":"Breast Cancer Res"},{"key":"3563_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1055\/s-2007-970601","volume":"68","author":"H Gumprecht","year":"2007","unstructured":"Gumprecht H, Grosu AL, Souvatsoglou M, Dzewas B, Weber WA, Lumenta CB (2007) 11C-methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas. Zentralblatt fur Neurochirurgie 68:19\u201323","journal-title":"Zentralblatt fur Neurochirurgie"},{"key":"3563_CR19","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.2967\/jnumed.110.084210","volume":"52","author":"WD Heiss","year":"2011","unstructured":"Heiss WD, Raab P, Lanfermann H (2011) Multimodality assessment of brain tumors and tumor recurrence. J Nucl Med 52:1585\u20131600. \n                    https:\/\/doi.org\/10.2967\/jnumed.110.084210","journal-title":"J Nucl Med"},{"key":"3563_CR20","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1212\/WNL.50.5.1316","volume":"50","author":"K Herholz","year":"1998","unstructured":"Herholz K, Holzer T, Bauer B, Schroder R, Voges J, Ernestus RI, Mendoza G, Weber-Luxenburger G, Lottgen J, Thiel A, Wienhard K, Heiss WD (1998) 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 50:1316\u20131322","journal-title":"Neurology"},{"key":"3563_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/neuonc\/nos300","volume":"15","author":"M Hutterer","year":"2013","unstructured":"Hutterer M, Nowosielski M, Putzer D, Jansen NL, Seiz M, Schocke M, McCoy M, Gobel G, la Fougere C, Virgolini IJ, Trinka E, Jacobs AH, Stockhammer G (2013) [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma. Neuro-Oncology 15:341\u2013351. \n                    https:\/\/doi.org\/10.1093\/neuonc\/nos300","journal-title":"Neuro-Oncology"},{"key":"3563_CR22","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1001\/jama.2012.12807","volume":"308","author":"AS Jakola","year":"2012","unstructured":"Jakola AS, Myrmel KS, Kloster R, Torp SH, Lindal S, Unsgard G, Solheim O (2012) Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA 308:1881\u20131888. \n                    https:\/\/doi.org\/10.1001\/jama.2012.12807","journal-title":"JAMA"},{"key":"3563_CR23","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00259-012-2109-9","volume":"39","author":"NL Jansen","year":"2012","unstructured":"Jansen NL, Graute V, Armbruster L, Suchorska B, Lutz J, Eigenbrod S, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougere C (2012) MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? Eur J Nucl Med Mol Imaging 39:1021\u20131029. \n                    https:\/\/doi.org\/10.1007\/s00259-012-2109-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3563_CR24","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/neuonc\/nos259","volume":"14","author":"NL Jansen","year":"2012","unstructured":"Jansen NL, Schwartz C, Graute V, Eigenbrod S, Lutz J, Egensperger R, Popperl G, Kretzschmar HA, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougere C, Thon N (2012) Prediction of oligodendroglial histology and LOH 1p\/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas. Neuro-Oncology 14:1473\u20131480. \n                    https:\/\/doi.org\/10.1093\/neuonc\/nos259","journal-title":"Neuro-Oncology"},{"key":"3563_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2967\/jnumed.113.122333","volume":"55","author":"NL Jansen","year":"2014","unstructured":"Jansen NL, Suchorska B, Wenter V, Eigenbrod S, Schmid-Tannwald C, Zwergal A, Niyazi M, Drexler M, Bartenstein P, Schnell O, Tonn JC, Thon N, Kreth FW, la Fougere C (2014) Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients. J Nucl Med 55:198\u2013203. \n                    https:\/\/doi.org\/10.2967\/jnumed.113.122333","journal-title":"J Nucl Med"},{"key":"3563_CR26","doi-asserted-by":"publisher","first-page":"274ra219","DOI":"10.1126\/scitranslmed.aaa2384","volume":"7","author":"M Jermyn","year":"2015","unstructured":"Jermyn M, Mok K, Mercier J, Desroches J, Pichette J, Saint-Arnaud K, Bernstein L, Guiot MC, Petrecca K, Leblond F (2015) Intraoperative brain cancer detection with Raman spectroscopy in humans. Sci Transl Med 7:274ra219. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.aaa2384","journal-title":"Sci Transl Med"},{"key":"3563_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/neuonc\/noq196","volume":"13","author":"M Kunz","year":"2011","unstructured":"Kunz M, Thon N, Eigenbrod S, Hartmann C, Egensperger R, Herms J, Geisler J, la Fougere C, Lutz J, Linn J, Kreth S, von Deimling A, Tonn JC, Kretzschmar HA, Popperl G, Kreth FW (2011) Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas. Neuro-Oncology 13:307\u2013316. \n                    https:\/\/doi.org\/10.1093\/neuonc\/noq196","journal-title":"Neuro-Oncology"},{"key":"3563_CR28","doi-asserted-by":"crossref","unstructured":"Langen K (2017) Positron-emission-tomography in diffuse low-grade gliomas. diffuse low-grade gliomas in adults, 2nd edn. Springer Nature, Springer","DOI":"10.1007\/978-3-319-55466-2_15"},{"key":"3563_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11060-017-2506-9","volume":"134","author":"K Leu","year":"2017","unstructured":"Leu K, Ott GA, Lai A, Nghiemphu PL, Pope WB, Yong WH, Liau LM, Cloughesy TF, Ellingson BM (2017) Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas. J Neuro-Oncol 134:177\u2013188. \n                    https:\/\/doi.org\/10.1007\/s11060-017-2506-9","journal-title":"J Neuro-Oncol"},{"key":"3563_CR30","doi-asserted-by":"publisher","first-page":"e0140917","DOI":"10.1371\/journal.pone.0140917","volume":"10","author":"B Malkowski","year":"2015","unstructured":"Malkowski B, Harat M, Zyromska A, Wisniewski T, Harat A, Lopatto R, Furtak J (2015) The sum of tumour-to-brain ratios improves the accuracy of diagnosing gliomas using 18F-FET PET. PLoS One 10:e0140917. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0140917","journal-title":"PLoS One"},{"key":"3563_CR31","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ijrobp.2017.12.258","volume":"100","author":"ES Murphy","year":"2018","unstructured":"Murphy ES, Leyrer CM, Parsons M, Suh JH, Chao ST, Yu JS, Kotecha R, Jia X, Peereboom DM, Prayson RA, Stevens GHJ, Barnett GH, Vogelbaum MA, Ahluwalia MS (2018) Risk factors for malignant transformation of low-grade glioma. Int J Radiat Oncol Biol Phys 100:965\u2013971. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2017.12.258","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3563_CR32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/brain\/awh399","volume":"128","author":"D Pauleit","year":"2005","unstructured":"Pauleit D, Floeth F, Hamacher K, Riemenschneider MJ, Reifenberger G, Muller HW, Zilles K, Coenen HH, Langen KJ (2005) O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 128:678\u2013687","journal-title":"Brain"},{"key":"3563_CR33","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00259-010-1457-6","volume":"37","author":"R Pichler","year":"2010","unstructured":"Pichler R, Dunzinger A, Wurm G, Pichler J, Weis S, Nubaumer K, Topakian R, Aigner RM (2010) Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance? Eur J Nucl Med Mol Imaging 37:1521\u20131528. \n                    https:\/\/doi.org\/10.1007\/s00259-010-1457-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3563_CR34","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1200\/JCO.2002.08.121","volume":"20","author":"F Pignatti","year":"2002","unstructured":"Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, Afra D, Cornu P, Bolla M, Vecht C, Karim AB, European Organization for R, Treatment of Cancer Brain Tumor Cooperative G, European Organization for R, Treatment of Cancer Radiotherapy Cooperative G (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20:2076\u20132084. \n                    https:\/\/doi.org\/10.1200\/JCO.2002.08.121","journal-title":"J Clin Oncol"},{"key":"3563_CR35","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3174\/ajnr.A3980","volume":"35","author":"T Pyka","year":"2014","unstructured":"Pyka T, Gempt J, Ringel F, Huttinger S, van Marwick S, Nekolla S, Wester HJ, Schwaiger M, Forster S (2014) Prediction of glioma recurrence using dynamic 18F-fluoroethyltyrosine PET. AJNR Am J Neuroradiol 35:1924\u20131929. \n                    https:\/\/doi.org\/10.3174\/ajnr.A3980","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"3563_CR36","first-page":"393","volume":"47","author":"G P\u00f6pperl","year":"2006","unstructured":"P\u00f6pperl G, Kreth FW, Herms J, Koch W, Mehrkens JH, Gildehaus FJ, Kretzschmar HA, Tonn JC, Tatsch K (2006) Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? Journal of nuclear medicine: official publication Society of Nuclear Medicine 47(3):393\u2013403","journal-title":"Journal of nuclear medicine: official publication Society of Nuclear Medicine"},{"key":"3563_CR37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1179\/174313213X13789811969265","volume":"27","author":"D Ribom","year":"2005","unstructured":"Ribom D, Smits A (2005) Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas. Neurol Res 27:516\u2013521","journal-title":"Neurol Res"},{"key":"3563_CR38","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1055\/s-2007-991143","volume":"50","author":"K Roessler","year":"2007","unstructured":"Roessler K, Gatterbauer B, Becherer A, Paul M, Kletter K, Prayer D, Hoeftberger R, Hainfellner J, Asenbaum S, Knosp E (2007) Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation. Minim Invasive Neurosurg 50:273\u2013280","journal-title":"Minim Invasive Neurosurg"},{"key":"3563_CR39","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1212\/WNL.59.6.947","volume":"59","author":"JN Scott","year":"2002","unstructured":"Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA (2002) How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59:947\u2013949","journal-title":"Neurology"},{"key":"3563_CR40","doi-asserted-by":"publisher","first-page":"372509","DOI":"10.1155\/2011\/372509","volume":"2011","author":"A Smits","year":"2011","unstructured":"Smits A, Baumert BG (2011) The clinical value of PET with amino acid tracers for gliomas WHO grade II. Int J Mol Imaging 2011:372509. \n                    https:\/\/doi.org\/10.1155\/2011\/372509","journal-title":"Int J Mol Imaging"},{"key":"3563_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00259-007-0531-1","volume":"35","author":"A Smits","year":"2008","unstructured":"Smits A, Westerberg E, Ribom D (2008) Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas. Eur J Nucl Med Mol Imaging 35:65\u201371","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3563_CR42","doi-asserted-by":"publisher","unstructured":"Suchorska B, Giese A, Biczok A, Unterrainer M, Weller M, Drexler M, Bartenstein P, Schuller U, Tonn JC, Albert NL (2017) Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1\/2 mutant diffuse astrocytoma. Neuro-Oncology. \n                    https:\/\/doi.org\/10.1093\/neuonc\/nox153","DOI":"10.1093\/neuonc\/nox153"},{"key":"3563_CR43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3174\/ajnr.A4460","volume":"37","author":"K Takano","year":"2016","unstructured":"Takano K, Kinoshita M, Arita H, Okita Y, Chiba Y, Kagawa N, Fujimoto Y, Kishima H, Kanemura Y, Nonaka M, Nakajima S, Shimosegawa E, Hatazawa J, Hashimoto N, Yoshimine T (2016) Diagnostic and prognostic value of 11C-methionine PET for nonenhancing gliomas. AJNR Am J Neuroradiol 37:44\u201350. \n                    https:\/\/doi.org\/10.3174\/ajnr.A4460","journal-title":"AJNR Am J Neuroradiol"},{"key":"3563_CR44","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1002\/ijc.29259","volume":"136","author":"N Thon","year":"2015","unstructured":"Thon N, Kunz M, Lemke L, Jansen NL, Eigenbrod S, Kreth S, Lutz J, Egensperger R, Giese A, Herms J, Weller M, Kretzschmar H, Tonn JC, la Fougere C, Kreth FW (2015) Dynamic 18F-FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses. Int J Cancer 136:2132\u20132145. \n                    https:\/\/doi.org\/10.1002\/ijc.29259","journal-title":"Int J Cancer"},{"key":"3563_CR45","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.2967\/jnumed.115.171033","volume":"57","author":"M Unterrainer","year":"2016","unstructured":"Unterrainer M, Schweisthal F, Suchorska B, Wenter V, Schmid-Tannwald C, Fendler WP, Schuller U, Bartenstein P, Tonn JC, Albert NL (2016) Serial 18F-FET PET imaging of primarily 18F-FET-negative glioma: does it make sense? J Nucl Med 57:1177\u20131182. \n                    https:\/\/doi.org\/10.2967\/jnumed.115.171033","journal-title":"J Nucl Med"},{"key":"3563_CR46","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00259-017-3846-6","volume":"45","author":"A Verger","year":"2018","unstructured":"Verger A, Stoffels G, Bauer EK, Lohmann P, Blau T, Fink GR, Neumaier B, Shah NJ, Langen KJ, Galldiks N (2018) Static and dynamic (18)F-FET PET for the characterization of gliomas defined by IDH and 1p\/19q status. Eur J Nucl Med Mol Imaging 45:443\u2013451. \n                    https:\/\/doi.org\/10.1007\/s00259-017-3846-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3563_CR47","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s11060-015-2004-x","volume":"126","author":"A Watanabe","year":"2016","unstructured":"Watanabe A, Muragaki Y, Maruyama T, Shinoda J, Okada Y (2016) Usefulness of 11C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions. J Neuro-Oncol 126:577\u2013583. \n                    https:\/\/doi.org\/10.1007\/s11060-015-2004-x","journal-title":"J Neuro-Oncol"},{"key":"3563_CR48","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/jnnp.2010.205229","volume":"82","author":"G Widhalm","year":"2011","unstructured":"Widhalm G, Krssak M, Minchev G, Wohrer A, Traub-Weidinger T, Czech T, Asenbaum S, Marosi C, Knosp E, Hainfellner JA, Prayer D, Wolfsberger S (2011) Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement. J Neurol Neurosurg Psychiatry 82:512\u2013520. \n                    https:\/\/doi.org\/10.1136\/jnnp.2010.205229","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3563_CR49","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3171\/2015.10.JNS15583","volume":"125","author":"M Zetterling","year":"2016","unstructured":"Zetterling M, Roodakker KR, Berntsson SG, Edqvist PH, Latini F, Landtblom AM, Ponten F, Alafuzoff I, Larsson EM, Smits A (2016) Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data. J Neurosurg 125:1155\u20131166. \n                    https:\/\/doi.org\/10.3171\/2015.10.JNS15583","journal-title":"J Neurosurg"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00701-018-3563-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-018-3563-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-018-3563-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T14:05:50Z","timestamp":1581948350000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00701-018-3563-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["3563"],"URL":"https:\/\/doi.org\/10.1007\/s00701-018-3563-3","relation":{},"ISSN":["0001-6268","0942-0940"],"issn-type":[{"value":"0001-6268","type":"print"},{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,24]]},"assertion":[{"value":"8 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Author J.G. is employed as a consultant for Brainlab. The remaining authors declare that he\/she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}